Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Accured Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt issuances Short-Term Debt repayments Wages, Salaries and Other

Scienture Holdings (SCNX) Shares Outstanding (2016 - 2025)

Scienture Holdings' Shares Outstanding history spans 13 years, with the latest figure at $40.6 million for Q4 2025.

On a quarterly basis, Shares Outstanding rose 257726.1% to $40.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.6 million, a 257726.1% increase, with the full-year FY2025 number at $40.6 million, up 257726.1% from a year prior.
Shares Outstanding hit $40.6 million in Q4 2025 for Scienture Holdings, up from $23.1 million in the prior quarter.
Over the last five years, Shares Outstanding for SCNX hit a ceiling of $40.6 million in Q4 2025 and a floor of $15759.0 in Q4 2023.
Historically, Shares Outstanding has averaged $6.2 million across 5 years, with a median of $681622.5 in 2023.
Biggest five-year swings in Shares Outstanding: tumbled 99.96% in 2024 and later surged 257726.1% in 2025.
Tracing SCNX's Shares Outstanding over 5 years: stood at $544430.0 in 2021, then rose by 15.03% to $626247.0 in 2022, then crashed by 97.48% to $15759.0 in 2023, then changed by 0.0% to $15759.0 in 2024, then surged by 257726.1% to $40.6 million in 2025.
Business Quant data shows Shares Outstanding for SCNX at $40.6 million in Q4 2025, $23.1 million in Q3 2025, and $15759.0 in Q2 2025.